Estimating the cost-effectiveness of nutrition supplementation for malnourished, HIV-infected adults starting antiretroviral therapy in a resource-constrained setting

Table 3 Maximum allowable quarterly supplement costs to maintain parity with ART alone

BMI category
Change in overall survival and retention at 6 months of ART with supplement	<16.0 kg/m ²	16.00-16.99 kg/m ²	17.00-18.49 kg/m ²
20% mortality benefit, no retention benefit	$5.49	$3.03	$1.94
No mortality benefit, 20% retention benefit	$5.48	$3.83	$3.23
20% mortality and 20% retention benefit	$10.99*	$6.86	$5.28
50% mortality and 50% retention benefit	$27.48†	$17.20†	$13.01*

*scenarios in which maize flour supplementation would be cost-effective.
†scenarios in which maize flour or corn-soya blend flour supplementation would be cost-effective.

ISSN: 1478-7547